Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.241,83
0,56%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Lineage Cell Therapeutics Inc (LCTX) Lineage Cell Therapeutics Inc (LCTX) Notizie

Lineage Cell Therapeutics Inc

LCTX
1,08
0,03 (2,86%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202423:17EDGAR2Form S-3 - Registration statement under Securities Act of..
07/3/202422:10EDGAR2Form 8-K - Current report
15/2/202423:27EDGAR2Form 8-K - Current report
13/2/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202403:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202400:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202400:57EDGAR2Form SC 13D/A - General statement of acquisition of..
06/2/202415:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/2/202415:20EDGAR2Form 8-K - Current report
06/2/202415:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03/1/202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202322:21APSTake Part in the Next Generation of Spinal Cord Injury..
13/11/202322:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202322:10EDGAR2Form 8-K - Current report
11/10/202316:00APSSmall Company Working on Big Breakthrough in Treating Spinal..
07/9/202323:01EDGAR2Form 8-K - Current report
10/8/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:10EDGAR2Form 8-K - Current report
27/7/202322:15EDGAR2Form ARS - Annual Report to Security Holders
27/7/202322:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
27/7/202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
11/7/202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
03/7/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 1,09 Min: 1,05 Max: 1,12
Chiusura: 1,05

La tua Cronologia

AMEX
LCTX
Lineage Cell Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network